| Patent | Date |
|---|
Process for the preparation of a PDE4 inhibitor
Grant 11,352,327 - Falchi , et al. June 7, 2 | 2022-06-07 |
Process For The Preparation Of A Pde4 Inhibitor
App 20210040040 - FALCHI; Alessandro ; et al. | 2021-02-11 |
Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
Grant 10,786,450 - Cavecchi , et al. September 29, 2 | 2020-09-29 |
Process for the preparation of a PDE4 inhibitor
Grant 10,759,761 - Falchi , et al. Sep | 2020-09-01 |
Process For The Preparation Of A Pde4 Inhibitor
App 20190345108 - FALCHI; Alessandro ; et al. | 2019-11-14 |
Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
Grant 10,350,164 - Cavecchi , et al. July 16, 2 | 2019-07-16 |
Process for the preparation of a PDE4 inhibitor
Grant 10,323,003 - Falchi , et al. | 2019-06-18 |
Process For Preparing A Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-adrenergic
App 20180325816 - CAVECCHI; Alessandro ; et al. | 2018-11-15 |
Process For Preparing A Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-adrenergic
App 20180325815 - CAVECCHI; Alessandro ; et al. | 2018-11-15 |
Process For The Preparation Of A Pde4 Inhibitor
App 20180118686 - FALCHI; Alessandro ; et al. | 2018-05-03 |
Process for the preparation of a PDE4 inhibitor
Grant 9,890,122 - Falchi , et al. February 13, 2 | 2018-02-13 |
Process For The Preparation Of A Pde4 Inhibitor
App 20160326117 - FALCHI; Alessandro ; et al. | 2016-11-10 |
Process for the preparation of a PDE4 inhibitor
Grant 9,434,691 - Falchi , et al. September 6, 2 | 2016-09-06 |
Novel Polymorphs And Salts
App 20160193165 - PIVETTI; Fausto ; et al. | 2016-07-07 |
Crystal form of glycopyrronium chloride
Grant 9,174,937 - Pivetti , et al. November 3, 2 | 2015-11-03 |
Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
Grant 9,056,818 - Pivetti , et al. June 16, 2 | 2015-06-16 |
Process For The Preparation Of A Pde4 Inhibitor
App 20150111931 - FALCHI; Alessandro ; et al. | 2015-04-23 |
Process For The Preparation Of Glycopyrronium Chloride
App 20140364479 - PIVETTI; Fausto ; et al. | 2014-12-11 |
Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
Grant 8,877,164 - Lewis , et al. November 4, 2 | 2014-11-04 |
Novel Polymorphs And Salts
App 20140135399 - Pivetti; Fausto ; et al. | 2014-05-15 |
Polymorphs and salts
Grant 8,673,978 - Pivetti , et al. March 18, 2 | 2014-03-18 |
Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
Grant 8,399,406 - Pivetti , et al. March 19, 2 | 2013-03-19 |
Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]ami- no]ethyl]-2(1H)-quinolinone monohydrochloride
Grant 8,163,922 - Pivetti , et al. April 24, 2 | 2012-04-24 |
Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
Grant 8,128,909 - Capocchi , et al. March 6, 2 | 2012-03-06 |
Crystal Form Of Glycopyrronium Chloride
App 20110305645 - Pivetti; Fausto ; et al. | 2011-12-15 |
Process For The Preparation Of Glycopyrronium Chloride
App 20110306650 - PIVETTI; Fausto ; et al. | 2011-12-15 |
Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
Grant 8,076,505 - Folleas , et al. December 13, 2 | 2011-12-13 |
Novel Polymorphs And Salts
App 20110245346 - Pivetti; Fausto ; et al. | 2011-10-06 |
8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]ami- No]ethyl]-2(1h)-quinolinone Hemi-fumarate
App 20110044913 - Pivetti; Fausto ; et al. | 2011-02-24 |
Process For The Preparation Of Derivatives Of 1-(2- Halobiphenyl-4-yl)-cyclopropanecarboxylic Acid
App 20110039934 - PIVETTI; Fausto ; et al. | 2011-02-17 |
Reconstituted Surfactant Composition Containing Analogs Of Surfactant Protein B (sp-b) And Surfactant Protein C (sp-c)
App 20110003733 - PIVETTI; FAUSTO ; et al. | 2011-01-06 |
Process For The Preparation Of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]ami- No]ethyl]-2(1h)-quinolinone Monohydrochloride
App 20090326231 - PIVETTI; Fausto ; et al. | 2009-12-31 |
Process Of Preparing Derivatives Of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic Acid
App 20090312426 - FOLLEAS; Benoit ; et al. | 2009-12-17 |
Polymorph Of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]am- Ino]ethyl]-2(1h)-quinolinone Monohydrochloride
App 20090280068 - PIVETTI; Fausto ; et al. | 2009-11-12 |
Crystal Form Of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]am- Ino]ethyl]-2(1h)-quinolinone Monohydrochloride
App 20090280067 - PIVETTI; Fausto ; et al. | 2009-11-12 |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
Grant 7,381,402 - Lewis , et al. June 3, 2 | 2008-06-03 |
8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation
App 20070197586 - Pivetti; Fausto ; et al. | 2007-08-23 |
Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
App 20070140980 - Capocchi; Andrea ; et al. | 2007-06-21 |
Stable Pharmaceutical Solution Formulations for Pressurized Metered Dose Inhalers
App 20070025920 - Lewis; David ; et al. | 2007-02-01 |
Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
App 20060193785 - Lewis; David Andrew ; et al. | 2006-08-31 |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
App 20050220718 - Lewis, David ; et al. | 2005-10-06 |
| 